Founded in 2014 Irvine Therapeutics is a leader focused on the development of pharmaceutical grade products in the field of cannabinoid prescription medications targeting a wide range of treatments.
The company portfolio consists of Epilene®, Procanol®, Serenex® and other pipeline medications in development.
Chris Lombardi - Chief Executive Officer
Mr. Lombardi is the the CEO of Procana Holdings which is the parent company to Irvine Therapeutics, Advanced Softgel and Procana Laboratories. His professional career has spanded as the CEO of Visionaire Optics, CEO of 2k Media Corporation, Vice President of ChromaGen, and executive management at DHL Worldwide. Mr. Lombardi attended Park University and also served in the U.S Marines where he received numerous awards for honors and achievement.
Peyman Salimi Tari M.D - Medical Director
Dr. Salimi-Tari graduated from UC Berkeley with a bachelor's degree in Biology and a bachelor's degree in Near Eastern Studies before attending medical school. Dr. Salimi-Tari also earned a Master's degree in Molecular Biology and worked in a biotech industry on a Prostate Cancer Research project for a short period of time, before attending medical school. Dr. Salimi-Tari completed his medical school at University of Sydney, Australia and completed his residency in Internal Medicine at the University of Florida, Jacksonville where he also completed his fellowship in Medical Oncology.
Medical & Scientific Board
Gerard Scarlato, Ph.D.
Dr. Scarlato received his Bachelor of Science in Biochemistry at the University of Wisconsin-Madison in the area of synthetic carbohydrate chemistry. He then went on to receive his Doctorate of Philosophy in Organic Chemistry at UCLA.
Areas of Focus / Expertise:
Haresh Jhangiani, M.D., FACP, MBA
Dr. Jhangiani is a board certified medical oncologist, and has been in clinical practice for 23 years, and is a leading expert in breast cancer, lung cancer, colon cancer, prostate cancer and pancreatic cancer. He was a chairman of the cancer committee at Fountain Valley Regional Hospital, and currently serves as CEO of Compassionate Cancer Care Medical Group. Dr. Jhangiani earned his M.B.B.S degree in Medicine at University of Mumbai, his MD, FACP, Health Care Admin degree at UC Irvine Medical School and the Paul Merage School of Business, FACP degree in Medical Oncology and Hematology at University of Southern California.
James Kao, D.O, MPH
Dr. Kao is a board-certified, fellowship trained physician and surgeon with many years of experience in Medicine, Public Health and Ophthalmology. He attained dual medical degrees from Western University of Health Sciences and International University of Health Sciences, as well as a Master's in Public Health from George Washington University. Additionally, he has experience in the biotechnology industry in the fields of quality assurance/quality control and research/development. Dr. Kao has been a proponent for the use of medical cannabis in the treatment of cancer, pain management, inflammatory/autoimmune and other conditions including but not limited to glaucoma, migraines, neuropathy, seizures, and gastrointestinal disorders.
Joseph Yi, M.D.
Dr Yi is an anesthesiolgist that hails from Philadelphia, PA and trained at the University of Pennsylvania. He has an extensive background in both clinical and laboratory research as well as pain medicine.
Irvine Therapeutics LLC.
30 Hughes #208
Irvine, CA 92618